New FDA-approved AI tool can predict whether breast cancer will return
INDIANAPOLIS — A new AI tool could help doctors better predict whether breast cancer will return, and it’s now received FDA approval. SimBioSys created TumorSight Risk, an AI-powered, MRI-derived, prognostic tool, using NVIDIA technology to assess breast cancer recurrence risk in individuals with early-stage hormone re
